Penumbra Inc (PEN)
NYSE · Healthcare · Medical Devices
Penumbra Inc is a Healthcare company with a market capitalization of $12.82B and a trailing P/E ratio of 80.2.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 6, 2026 | $0.82 | $1.08 | -24.1% |
| Q4 2025 | February 25, 2026 | $1.18 | $1.10 | +7.3% |
| Q3 2025 | November 5, 2025 | $0.97 | $0.92 | +5.4% |
| Q2 2025 | July 29, 2025 | $0.86 | $0.82 | +4.9% |
| Q1 2025 | April 23, 2025 | $0.83 | $0.67 | +23.9% |
| Q4 2024 | February 18, 2025 | $0.97 | $0.89 | +8.5% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 2,123,757 | 5.37% | 6.3 | +4.2% |
| June 30, 2026 | 2,037,620 | 5.15% | 5.1 | +2.5% |
| June 15, 2026 | 1,986,919 | 5.02% | 4.6 | +3.7% |
| May 29, 2026 | 1,916,131 | 4.85% | 4.2 | -0.0% |
| May 15, 2026 | 1,916,276 | 4.85% | 4.7 | +1.0% |
| April 30, 2026 | 1,896,966 | 4.82% | 3.3 | -5.5% |
| April 15, 2026 | 2,007,168 | 5.10% | 4.2 | -17.7% |
| March 31, 2026 | 2,437,639 | 6.19% | 3.7 | +18.3% |
Other Medical Devices Stocks
Frequently Asked Questions
What is Penumbra Inc's market cap?
As of August 13, 2026, Penumbra Inc (PEN) has a market capitalization of $12.82B.
What is Penumbra Inc's P/E ratio?
Penumbra Inc trades at a trailing price-to-earnings (P/E) ratio of 80.2. Its forward P/E is 68.2.
Does Penumbra Inc pay a dividend?
Penumbra Inc does not currently pay a dividend.
What sector is PEN in?
Penumbra Inc is in the Healthcare sector, specifically the Medical Devices industry.
What is Penumbra Inc's short interest?
As of the July 15, 2026 FINRA settlement, 2,123,757 PEN shares were sold short, or 5.37% of shares outstanding. Days to cover: 6.3. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was Penumbra Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Penumbra Inc reported revenue of $1.40B and net income of $177.69M.
Ask your own questions about PEN
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.